In the transgenic mice of ALS expressing G93A-superoxide dismutase 1 (SOD1-G93A), long-term IL-33 administration delays disease onset in females but not males probably through peripheral Th2 response (115). Here, SOD1 is linked to amyotrophic lateral sclerosis.